HAEMATO AG Share Price Xetra

Equities

HAEK

DE000A289VV1

Pharmaceuticals

Market Closed - Xetra 10:06:27 29/02/2024 pm IST 5-day change 1st Jan Change
21.4 EUR -1.83% Intraday chart for HAEMATO AG -.--% -23.02%
6 months-20.74%
Current year-23.02%

Financials

Sales 2023 * 268M 287M 23.95B Sales 2024 * 281M 301M 25.11B Capitalization 88.87M 95.19M 7.94B
Net income 2023 * 7M 7.5M 625M Net income 2024 * 10M 10.71M 893M EV / Sales 2023 * 0.25 x
Net cash position 2023 * 21.2M 22.71M 1.89B Net cash position 2024 * 24.2M 25.93M 2.16B EV / Sales 2024 * 0.23 x
P/E ratio 2023 *
-
P/E ratio 2024 *
-
Employees 76
Yield 2023 *
-
Yield 2024 *
-
Free-Float 99.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.83%
6 months-20.74%
Current year-23.02%
More quotes
Current year
20.00
Extreme 20
28.00
1 year
20.00
Extreme 20
28.00
3 years
13.65
Extreme 13.65
29.80
5 years
13.65
Extreme 13.65
50.80
10 years
13.65
Extreme 13.65
71.99
More quotes
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic drugs with focus on oncology, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), neurology, rheumatology, urology, cardiovascular diseases and other chronic diseases. The Company's main markets are Europe, North America and Japan. It also imports medicines from within the European Economic Area in form of parallel imports and re-imports. The Company's subsidiaries are Haemato Pharm GmbH, Heamato Med GmbH, Castell Pharma BV, Sanate GmbH and Heamato Asia Co Ltd. Customers can order medicine through phone, fax and e-mail, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Quarterly revenue - Rate of surprise